Improved survival of idiopathic dilated cardiomyopathy in the 1990s

Japanese Circulation Journal

Volumn 63, Issue 5, 1999, Pages 333-338

  Azuma, Akihiro ^a   Matsuo, Akiko ^a   Nakamura, Takashi ^b   Kawasaki, Tatsuya ^a   Yamamoto, Kazuto ^a   Hyogo, Masayuki ^a   Hirata, Atsuhide ^a   Hirasaki, Satoshi ^a   Shima, Takatomo ^a   Sugihara, Hiroki ^a   Kunishige, Hiroshi ^c   Kuribayashi, Toshiro ^a   Nakagawa, Masao ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b Medical Care Center   (Japan)

^c MATSUSHITA MEMORIAL HOSPITAL   (Japan)

Author keywords

Beta blockers; Dilated cardiomyopathy; Mortality; Prognosis

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CONGESTIVE CARDIOMYOPATHY; DISEASE CLASSIFICATION; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT SELECTION; PROGNOSIS; SURVIVAL TIME;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIOMYOPATHY, DILATED; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS; VENTRICULAR FUNCTION, LEFT;

EID: 0347115911     PISSN: 00471828     EISSN: None     Source Type: Journal    
DOI: 10.1253/jcj.63.333     Document Type: Article

References (18)

1. Fuster V, Gersh BJ, Giuliani ER, Tajik AJ, Brandenburg RO, Frye RL: The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol 1981; 47: 525-531
2. Franciosa JA, Wilen M, Ziesche S, Cohn JN: Survival in men with severe chronic left ventricular failure due to either coronary heart disease of idiopathic dilated cardiomyopathy. Am J Cardiol 1983; 51: 831-836
3. Rich MW, Brook K, Luther P: Temporal trends in pharmacotherapy for congestive heart failure at an academic medical center: 1990-1995. Am Heart J 1998; 135: 367-372
4. The CONSENSUS trial study group: Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Eng J Med 1987; 316: 1429-1435
5. Cohn JN, Johnson G, Ziesche S, Cobb F, Francis G, Tristani F, et al: A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991; 325: 303-310
6. The SOLVD Investigators: Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325: 293-302
7. Waagstein F, Hjalmarson Å, Varnauskas E, Wallentin I: Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J 1975; 37: 1022-1036
8. Swendberg K, Hjalmarson Å, Waagstein F, Wallentin I: Prolongation of survival in congestive cardiomyopathy by β-receptor blockade. Lancet 1979; i: 1374-1376
9. Engelmeier RS, O'Connel JB, Walsh R, Rad N, Scanlon PJ, Gunnar RM: Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double blind, randomized, placebo-controlled trial. Circulation 1985; 72: 536-546
10. Sano H, Kawabata N, Yonezawa K, Hirayama H, Sakuma I, Yasuda H: Metoprolol was more effective than captopril for dilated cardiomyopathy in Japanese patients. Circulation 1989; 89(Suppl II): II-118
11. Yokota Y, Nomura H, Kawai H, Tsumura Y, Takeuchi Y, Kurozumi H, et al: Effects of long-term β-blockade (metoprolol) therapy in patients with dilated cardiomyopathy. Jpn Circ J 1991; 55: 343-355
12. Waagstein F, Bristow MR, Swedberg K, Camerini F, Fowler MB, Silver MA, et al, for the Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group: Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet 1993; 342: 1441-1446
13. CIBIS investigators and committees: A randomized trial of β-blockade in heart failure: The cardiac insufficiency bisoprolol study (CIBIS). Circulation 1994; 90: 1765-1773
14. Epstein AE, Bigger JT Jr, Wyse DG, Romhilt DW, Reynolds-Haertle RA, Hallstrom AP and the CAST investigators: Events in the Cardiac Arrhythmia Suppression Trial (CAST): Mortality in the entire population enrolled. J Am Coll Cardiol 1991; 18: 14-19
15. The Cardiac Arrhythmia Suppression Trial investigators: Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. N Engl J Med 1992; 327: 227-233
16. Packer M, Carver JR, Rodeheffer RJ, Ivanhoe RJ, DiBianco R, Zeldis SM, et al, for the PROMISE study research group: Effect of oral milrinone on mortality in severe chronic heart failure. N Engl J Med 1991; 325: 1468-1475
17. Heidenreich PA, Lee TT, Massie BM: Effect of beta-blockade on mortality in patients with heart failure: A meta-analysis of randomized clinical trials. J Am Coll Cardiol 1997; 30: 27-34
18. Di Lenarda A, Secoli G, Perkan A, Gregori D, Lardieri G, Pinamonti B, et al, the Heart Muscle Disease Study Group: Changing mortality in dilated cardiomyopathy. Br Heart J 1994; 72(Suppl): S46-S51